These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6152138)

  • 21. [Beta blockers in arrhythmias].
    Fuhrer J
    Praxis (Bern 1994); 1995 Mar; 84(11):304-12. PubMed ID: 7724946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacologic limitation of the size of the myocardial infarction (excluding thrombolysis)].
    Zannad F; Gilgenkrantz JM; Royer RJ
    Ann Cardiol Angeiol (Paris); 1985; 34(7):467-73. PubMed ID: 2865926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockade in myocardial ischemia: acute interventions in myocardial infarction.
    Bleifeld WH
    J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S56-8. PubMed ID: 2468836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Betablocker therapy in acute myocardial infarction].
    Danchin N; Angioi M; Preiss JP; Jacquemin L; Houriez P
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():43-7. PubMed ID: 9749276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
    Furberg CD; Bell RL
    Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
    Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitation of infarct size by beta blockers and its potential role for prognosis.
    Hjalmarson A; Herlitz J
    Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy with beta receptor blockers in myocardial infarct].
    Hohnloser SH; Klingenheben T
    Z Kardiol; 1994 Nov; 83(11):824-9. PubMed ID: 7825372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnesium sulfate in acute myocardial infarction].
    Balli E; Giomi A; Del Citerna F
    G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance.
    Ibanez B; Prat-González S; Speidl WS; Vilahur G; Pinero A; Cimmino G; García MJ; Fuster V; Sanz J; Badimon JJ
    Circulation; 2007 Jun; 115(23):2909-16. PubMed ID: 17515460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The late open artery hypothesis at the crossroad. The ACTOR study: aggressive versus conservative treatment of the infarct-related artery after acute MI. ACTOR Study Group.
    G Ital Cardiol; 1999 Jan; 29(1):1-10. PubMed ID: 9987041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New aspects in the prophylaxis of myocardial reinfarction (author's transl)].
    Hitzenberger G
    Aktuelle Gerontol; 1982 Jan; 12(1):7-11. PubMed ID: 6121504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.